. . .erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the . advertisement . . .and parents who refuse to vaccinate their children should consider what they are doing to other young kids in their communities. .